Popular Articles
Today Week Month Year


PAID OFF: COVID origins investigator wins $1M via China’s “Nobel Prize” for claiming virus developed naturally
By Mary Villareal // Oct 21, 2021

Dr. Malik Peiris, a former member of the Lancet task force looking into the Wuhan coronavirus (COVID-19) pandemic, has received China's "Nobel Prize" for research that affirms the narrative that the disease developed naturally.

Brighteon.TV

Peiris is a Sri Lankan virologist working in Hong Kong and one of 12 scientists who led the Lancet probe into the origins of the disease. The task force is no longer listed on the medical journal's website as it was forced to disband due to extensive conflicts of interest with the Wuhan Institute of Virology, although archived web pages reveal the participation of Peiris.

Following his work with the task force, the Chinese Communist Party (CCP) awarded Peiris with a prize in life science during the 2021 Future Science Prize – also known as China's own version of the Nobel Prize. The award comes with a hefty sum of $1 million funded by several CCP-linked companies, such as Baidu, Hillhouse Capital and Sequoia Capital China.

A state-run media outlet claimed that the award, which he shared with co-author Kwok-Yung Yuen, was for his "major discoveries of SARS-CoV-1 as the causative agent of the global SARS outbreak in 2003 with impact on combating COVID-19 and emerging infectious diseases." (Related: Chinese authorities hid the fact that medical staff in coronavirus-hit city were infected.)

Peiris' research played integral role in "tracing" COVID-19 origins

During the SARS outbreak in 2003, Peiris, Yuen and their team treated the first patients in Hong Kong and isolated the SARS-CoV-1 from their clinical specimens, which became critical to the design of diagnostic tests and disease characterization. In addition, Yuen's continued studies on SARS-like viruses in wild bats increased the knowledge of zoonotic reservoirs, barriers to cross-species transmission, pathogenesis and clinical diagnosis of the diseases.

Peiris' research was praised by reviewers for playing an integral role in tracing the origins of COVID-19, saying that Chinese scientists were able to identify the cause of the pandemic quickly because of his contributions. The research particularly bolstered the CCP's narrative that COVID-19 developed naturally as opposed to having been leaked or escaped from a lab.

As the media outlet explained, Peiris' research helped support the narrative that SARS-CoV-2 originated from bats.

When asked how their discoveries affected people's understanding of the cause of COVID-19, Yuen explained that since he and his team discovered in 2005 the horseshoe bat being a natural animal reservoir for the ancestral SARS-CoV-1, they believe that the SARS-CoV-2 "also went from bats to another mammal before jumping into humans."

Moreover, their studies have shown that SARS-CoV-2 replicates very well in both bat and human intestinal organs, which further supports the theory of the SARS-CoV-2 beginnings.

However, there are also major differences between the two diseases, especially in terms of severity, asymptomatic or mildly symptomatic rates and the ability to suppress interferon and inflammatory responses.

As scientists call for the second phase of its origins, Chinese experts have suggested conducting investigations in countries where horseshoe bats and pangolins reside.

Jin Dongyan, a professor at the School of Biomedical Sciences at Hong Kong University, said that Peiris, Yuen and their research team were very valuable to the Hong Kong Special Administrative Region.

"From SARS to COVID-19, the team has been engaged in coronavirus-related basic studies while combing through clinical studies. That working mode contributes the outstanding work of the university to the study of infectious diseases," he said.

There had been 20 winners of the Future Science Prize in the last five years, all of whom have been widely recognized in the scientific circle and society. The late Yuan Longping, also known as "the father of hybrid rice," was awarded the prize in 2018 "for pioneering the use of hybrid vigor to achieve higher yield and increased stress resistance in rice."

Get more news and updates on the development of COVID-19 at Pandemic.news.

Sources include:

TheNationalPulse.com

Finance.Yahoo.com

GlobalTimes.cn



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.